Pastør21 AI earns awardable status in DARPA ERIS Marketplace

Pastør21 AI said July 6, 2026, that its explainable-AI genomic intelligence platform has been deemed awardable in DARPA’s ERIS Marketplace. The designation could put the company’s pathogen surveillance and biothreat attribution tools in front of government buyers for defense and public health use.

Why it matters: - Pastør21 AI’s ERIS Marketplace status gives the company a path to government selection, negotiation and award for a platform aimed at pathogen surveillance and biothreat attribution. - The designation matters because DARPA uses the marketplace to speed procurement of technologies for defense and security missions. - Government customers can review awardable solutions through the marketplace and move faster from assessment to acquisition.

What happened: - Pastør21 AI announced July 6, 2026, that it achieved “awardable” status through DARPA’s Expedited Research Innovation System, or ERIS, Marketplace. - Jonathan Monk, co-founder and CTO of Pastør21 AI, said the status moves the platform from competitive assessment toward mission use. - The company’s video solution is accessible only to government customers with a .mil email address on the DARPA ERIS Marketplace. - Government customers can create an ERIS Marketplace account at More information.

The details: - Pastør21 AI describes its software as explainable-AI genomic-intelligence tools for pathogen surveillance and biothreat attribution. - The platform is designed to turn global genomic data into pathogen identification and field-deployable attribution results. - The showcased use case is titled “Building a High-Resolution Global Pangenome Database for Rapid Surveillance and In-Field Diagnosis.” - The company says the system decomposes pathogen pangenomes into “phylons,” defined as sets of co-occurring genes that define closely related strain subgroups. - Those phylons are used to generate DNA-marker signatures for rapid in-field diagnosis and biothreat attribution. - Pastør21 AI says its platform runs on edge devices even without network connectivity. - The company says its system is validated against a worldwide pipeline of clinical isolates annotated with treatment and outcome histories. - For media requests, contact media@p21ai.com.

Between the lines: - Awardable status does not equal a contract, but it does put Pastør21 AI inside a DARPA-vetted channel that can shorten the path to procurement. - The company is positioning its technology around explainability, field use and attribution, which are all important in defense and public health settings where decision speed and traceability matter. - The ERIS Marketplace is also a signal that DARPA is trying to pull in smaller, specialized vendors more quickly than traditional acquisition channels allow.

What’s next: - Government buyers with Marketplace access can review the video solution and decide whether to pursue selection, negotiation or award. - Pastør21 AI is likely to use the awardable designation to advance discussions with defense and public health customers. - DARPA’s marketplace contacts for other requests are eris@darpa.mil and outreach@darpa.mil.

The bottom line: - Pastør21 AI now has a DARPA-backed procurement pathway for its genomic intelligence platform, and that could help move its biothreat attribution tools from demo to deployment.